Hyperimmunized patients awaiting cadaveric kidney graft: Is there a quick desensitization possible?

被引:1
|
作者
Faenza, A. [1 ]
Fuga, G. [1 ]
Bertelli, R. [1 ]
Scolari, M. P. [2 ]
Buscaroli, A. [2 ]
Stefoni, S. [2 ]
机构
[1] S Orsola Univ Hosp, Dept Kidney Transplant Surg & Nephrol, Bologna, Italy
[2] S Orsola Univ Hosp, Dept Dialysis & Transplantat, Bologna, Italy
关键词
D O I
10.1016/j.transproceed.2008.05.078
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
On all kidney waiting lists the 10% to 20% of patients who have antibodies against more than 80% of a panel of HLA antigens (panel reactive antibody [PRA] > 80%) are difficult to transplant. The best solution for these patients is to find a compatible donor, ideally a full match, who yields a negative crossmatch test (CMX). If this is not possible, desensitization treatment (high-dose) intravenous immunoglobulin (IVIG) or plasmapheresis (PP) + low-dose IVIG is possible with good results in living donor kidney transplantation mainly if the antibody titer is low. It may also be offered to patients awaiting cadaveric donors too after a long waiting time; however, when applied for several months, it has the obvious disadvantage of giving the patient the risk for long-lasting immunologic weakness without the certitude of finding a kidney. In one of our recent cases of combined liver plus kidney transplantation, a positive CMX became negative 8 hours after the liver operation; the kidney was transplanted with a good result which lasted over 3 years. This observation Suggested the possibility of a quick desensitization protocol in selected patients with a large (but not strong) immunization who probably are the majority. Patients sensitized to IVIG and with low titer PRA could be given a single PP + low-dose IVIG (what can be done within the time limit of cadaveric donor kidney transplantation) with good probability of turning an initial positive CMX to negative with the possibility of performing the operation and the advantage of giving the immunosuppression only when the kidney is present.
引用
收藏
页码:1833 / 1838
页数:6
相关论文
共 50 条
  • [31] Desensitization Therapy with Immunoglobulin (IVIG) and Rituximab for Patients Awaiting Heart Transplantation
    Patel, J.
    Kittleson, M.
    Rafiei, M.
    Stern, L.
    Chang, D.
    Czer, L.
    Trento, A.
    Kobashigawa, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S161 - S161
  • [32] Pharmaceutical Costs of Desensitization Therapy in Patients Awaiting Lung Transplantation in France
    Liu, Annae
    Bernard, Melisande
    BIODRUGS, 2014, 28 (01) : 55 - 61
  • [33] Autonomic dysregulation in patients awaiting kidney transplantation
    Hathaway, DK
    Cashion, AK
    Milstead, EJ
    Winsett, RP
    Cowan, PA
    Wicks, MN
    Gaber, AO
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (02) : 221 - 229
  • [34] Impact of delayed graft function on cadaveric kidney transplant outcome
    Gentil, MA
    Alcaide, MP
    Algarra, GR
    Pereira, P
    Toro, J
    González-Roncero, F
    López, M
    Bernal, G
    Mateos, J
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (02) : 689 - 691
  • [35] Single HLA antigen tests in hyperimmunized patients: Usefullness for kidney allocation
    Cesbron-Gautier, Anne
    Simon, Philippe
    Cury, Sylvie
    Leforestier, Maguy
    Devys, Anne
    Hourmant, Maryvonne
    Bignon, Jean-Denis
    HUMAN IMMUNOLOGY, 2006, 67 (10) : S75 - S75
  • [36] A randomized controlled trial of pentoxifylline for the prevention of delayed graft function in cadaveric kidney graft
    Noel, C
    Hazzan, M
    Coppin, MC
    Codaccioni, MX
    Pruvot, FR
    Labalette, M
    Lelievre, G
    CLINICAL TRANSPLANTATION, 1997, 11 (03) : 169 - 173
  • [37] Growth in children after kidney transplantation with living related donor graft or cadaveric graft
    Pape, L
    Ehrich, JHH
    Zivicnjak, M
    Offner, G
    LANCET, 2005, 366 (9480): : 151 - 153
  • [38] CAUSES OF GRAFT LOSS AND MORTALITY IN CYCLOSPORINE-TREATED CADAVERIC KIDNEY GRAFT RECIPIENTS
    FRODIN, L
    BACKMAN, U
    BREKKAN, E
    CLAESSON, K
    FLATMARK, A
    GABEL, H
    LARSSON, A
    LUNDGREN, G
    PERSSON, H
    SJOBERG, O
    TUFVESON, G
    WAHLBERG, JA
    TRANSPLANTATION PROCEEDINGS, 1987, 19 (01) : 1831 - 1832
  • [39] Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly Human Leukocyte Antigen-Sensitized Patients Awaiting Kidney Transplantation
    Rehman, Shehzad
    Meier-Kriesche, Herwig-Ulf
    Scornik, Juan
    TRANSPLANTATION, 2010, 90 (08) : 932 - 932
  • [40] Desensitization of highly HLA sensitized crossmatch (+) patients awaiting living donor (LD) kidney transplantation using IVIG plus Rituximab
    Vo, Ashley A.
    Chang, Robert
    Toyoda, Mieko
    Reinsmoen, Nancy
    Lukovsky, Marina
    Peng, Alice
    Villicana, Rafael
    Jordan, Stanley C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 353 - 353